# Toxoplasma gondii Infection and Proinflammatory Cytokine Level Assessment in Patients With Myocardial Infarction in Iraq: A Case–Control Study

**Authors:** Al-Abbas Fadhil Jasim, Amal Khudair Khalaf

PMC · DOI: 10.1155/cjid/2553949 · The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale · 2026-03-02

## TL;DR

This study found that Toxoplasma gondii infection and higher levels of proinflammatory cytokines are more common in patients with myocardial infarction in Iraq.

## Contribution

The study is the first to assess T. gondii infection and cytokine levels in MI patients in Iraq, linking them to immune-mediated pathways.

## Key findings

- MI patients had significantly higher anti-Toxoplasma IgG and IgM antibody rates compared to controls.
- IFN-γ and TGF-β serum and gene expression levels were significantly elevated in MI patients.
- T. gondii may contribute to MI through immune-mediated inflammatory pathways.

## Abstract

Toxoplasma gondii infections have been implicated in cardiac complications in both humans and animals, including myocarditis and pericarditis. This study surveyed the frequency of T. gondii antibodies and investigated the serum concentrations and gene expression profiles of interferon‐gamma (IFN‐γ) and transforming growth factor‐beta (TGF‐β) in myocardial infarction (MI) patients in Iraq.

This study was conducted on MI (case) and non‐MI healthy (control) individuals (200 participants/each group) in Baghdad, Iraq. The frequency of IgG and IgM anti‐Toxoplasma antibodies and the serum and expression level of IFN‐γ and TGF‐β were assessed by serological and real‐time PCR.

The frequency of anti‐Toxoplasma IgG and IgM antibodies in the patient group was reported to be 55.5% and 4.5%, respectively, while in the non‐MI group, this rate was observed to be 42.9% and 2.5%. In addition, both serum levels and gene expression levels of IFN‐γ and TGF‐β were meaningfully higher in the MI group compared to the non‐MI control group (p ≤ 0.001).

The present study revealed that individuals with MI exhibited significantly higher concentrations of anti–T. gondii antibodies compared to non‐MI. The data further suggest that IFN‐γ and TGF‐β serve as critical biomarkers connected in the pathogenesis of MI. Our findings propose that T. gondii may contribute to the development of MI via immune‐mediated inflammatory pathways. This observation indicates potential molecular similarities between the pathological elements of MI and the T. gondii pathogen. Moreover, the elevated expression of IFN‐γ and TGF‐β may offer a respected context for investigating the involvement of T. gondii in MI pathophysiology.

## Linked entities

- **Genes:** IFNG (interferon gamma) [NCBI Gene 3458], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040]
- **Diseases:** myocardial infarction (MONDO:0005068), myocarditis (MONDO:0004496), pericarditis (MONDO:0005904)
- **Species:** Toxoplasma gondii (taxon 5811)

## Full-text entities

- **Genes:** POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** pericardial effusion (MESH:D010490), myocarditis (MESH:D009205), scarring (MESH:D002921), arrhythmias (MESH:D001145), Acquired Immunodeficiency Syndrome (MESH:D000163), malignancies (MESH:D009369), mitochondrial dysfunction (MESH:D028361), Fibrosis (MESH:D005355), inflammatory (MESH:D007249), T. gondii infection (MESH:D014123), infectious disease (MESH:D003141), tissue injury (MESH:D017695), necrosis (MESH:D009336), coronary atherosclerosis (MESH:D003324), Toxoplasma infection (MESH:D014125), cardiac complications (MESH:D006331), cardiac hypertrophy (MESH:D006332), heart failure (MESH:D006333), ischemic injury (MESH:D017202), MI (MESH:D009203), toxoplasmic encephalomyelitis (MESH:D004679), Infection (MESH:D007239), cardiovascular conditions (MESH:D002318), ventricular hypertrophy (MESH:D024741), atherogenic (MESH:D050197), deaths (MESH:D003643), pericarditis (MESH:D010493)
- **Chemicals:** clindamycin (MESH:D002981), atovaquone (MESH:D053626), sulfadiazine (MESH:D013411), azithromycin (MESH:D017963), fatty acid (MESH:D005227), cotrimoxazol (-)
- **Species:** Toxoplasma gondii (species) [taxon 5811], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12951694/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12951694/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12951694/full.md

---
Source: https://tomesphere.com/paper/PMC12951694